Popular Articles
Natural Remedies

Report Looks At HIV Prevalence Among Chicago Gay Men
In Chicago, 17.4 percent of gay men are estimated to be HIV-positive, compared with 1.2 percent of the general male population, according to a new report by the Chicago Public Health Department, the Chicago Sun-Times reports. The report is based on data collected from 570 Chicago men through the National HIV Behavioral Surveillance system, and found that half of the men with HIV were unaware they were infected (Thomas, 7/25). "Health officials said Friday, information in the report on HIV infection mark the first time Chicago health officials have used blood-testing to determine infection rates among men," the AP/Chicago Tribune reports. In the past, estimates have relied on interviews with gay and bisexual men, according to Christopher Brown, the Public Health Department assistant commissioner. The report also found that "black men who have sex with other men have double the HIV infection rates of white and Hispanic men," the AP/Tribune reports (7/24).
generic viagra online
Obama Nominates Genetics Researcher Collins To Be NIH Director
President Obama on Wednesday nominated Francis Collins, a physician and genetics researcher, to be NIH director, the Washington Post reports (Brown, Washington Post, 7/9). Collins worked at the agency during the administrations of former Presidents Clinton and George W. Bush and served as director of the National Human Genome Research Institute, where he helped lead the Human Genome Project to sequence all human DNA (Young, The Hill, 7/8). He is also known for a 2006 best-selling book presenting scientific evidence for a belief in God. Collins resigned as head of the institute last year but remained a consultant. Since then, he established the BioLogos Foundation to "contribute to the public voice that represents the harmony of science and faith" (Maugh, Los Angeles Times, 7/9).Many researchers and health care experts praised Collins" nomination, though some others were not "entirely enthusiastic," according to the New York Times. The two major objections to his nomination involve his "very public embrace of religion" and his "important role in raising expectations [of gene research] impossibly high," according to the New York Times (Harris, New York Times, 7/9). Collins and his colleagues at the University of Michigan discovered the defective gene that causes cystic fibrosis in 1989. According to the Los Angeles Times, Collins is expected to be quickly confirmed (Los Angeles Times, 7/9).Broadcast Coverage NPR"s "Morning Edition" on Thursday included a discussion with NPR science correspondent Jon Hamilton about the nomination (Inskeep, "Morning Edition," NPR, 7/9).
News of the day
Informa Healthcare To Launch Beta Site
Informa Healthcare - one of the world"s leading medical and scientific publishers - has announced that the new interactive http://www.informahealthcare.com beta site will go live in July.
Cardiovascular

NPS RADAR Reviews Rivaroxaban - Oral Anticoagulant For Post-knee Replacement Surgery, Australia

Prescribers treating patients who have had total hip or knee replacement surgery can access an independent review of the oral anticoagulant rivaroxaban (Xarelto) in the August issue of NPS RADAR. NPS RADAR provides independent information about new medicines and changes to PBS listings to health professionals and is published to coincide with PBS updates, giving health professionals access to information when they need it. "GPs and pharmacists may see patients who have been initiated on rivaroxaban in hospital. They should be aware that rivaroxaban has only been evaluated for use in preventing deep vein thrombosis and pulmonary embolism after elective total hip or total knee replacement surgery," NPS senior adviser, quality use of medicines, Judith Mackson said. "Duration of the therapy is 14 days after knee replacement or 35 days after hip replacement and no longer. Some patients will need a GP prescription soon after discharge to cover the remaining duration of therapy. GPs will need to take into account the number of tablets the hospital has provided when selecting a suitable pack size and instructing the patient on how many tablets to take." Dose adjustment and titration, and monitoring of prothrombin time are not required. As with other anticoagulants, managing the risk of bleeding is a primary concern, and patients should be alert to possible signs of bleeding. "Prescribers should be aware that there are only small differences in efficacy and safety between rivaroxaban, low molecular weight heparins (Clexane and Fragmin), fondaparinux (Arixtra) and dabigatran (Pradaxa)," Ms Mackson said. Other topics covered in the latest edition of NPS RADAR include: - Hydromorphone prolonged-release tablets (Jurnista) for chronic severe disabling pain - Oxybutynin patch (Oxytrol) PBS listed as an alternative for overactive bladder - Update on PBS listings for Aboriginal peoples and Torres Strait Islanders - Sitagliptin with metformin - (Janumet) fixed-dose combination tablets PBS listed for type 2 diabetes mellitus - Risedronate (Actonel Once-a-month) and summary of anti-resorptive drug listings - Lanthanum (Fosrenol) tablets for adults with chronic kidney disease who are on dialysis http://www.nps.org.au/radar National Prescribing Service.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):